Also trades as: 0I1B.L (LSE) · $vol 0M

$17.77

-0.28 (-1.55%)

Weekly Expected Move ±7.6%

$15 $16 $18 $19 $20

NYSE · Healthcare · Medical - Devices · Tech Score Sell · Power 41 · $1.0B mcap · 57M float · 2.44% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

63.4 / 100

NoneWeakNarrowWide

Primary source: Intangible Assets · ROIC: -13.5% · 5Y Avg: -7.3%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ENOV has a Narrow competitive edge (63.4/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. Negative ROIC of -13.5% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$27

Low

$34

Avg Target

$45

High

Based on 4 analysts since Aug 6, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 12Hold: 3Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$35.71

Analysts7

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-09-01	BTIG	—	$41	$36	-5	+75.4%	$20.53
2026-09-01	BMO Capital	—	$30	$27	-3	+24.6%	$21.67
2026-08-17	Canaccord Genuity	—	$50	$45	-5	+72.7%	$26.06
2026-08-07	BMO Capital	Vik Chopra	$29	$30	+1	+14.0%	$26.31
2026-07-28	UBS	—	$50	$51	+1	+80.5%	$28.25
2026-07-08	BMO Capital	—	Initiated	$29	—	+22.7%	$23.63
2026-07-06	Evercore ISI	—	$36	$32	-4	+31.2%	$24.39
2026-05-08	Evercore ISI	—	$40	$36	-4	+32.0%	$27.27
2026-02-26	Needham	Mike Matson	$65	$52	-13	+104.6%	$25.42
2026-01-06	BTIG	Ryan Zimmerman	Initiated	$41	—	+51.8%	$27.01
2026-01-05	Evercore ISI	—	$62	$40	-22	+50.0%	$26.66
2026-01-05	UBS	Danielle Antalffy	Initiated	$50	—	+82.0%	$27.47
2025-12-17	Canaccord Genuity	—	Initiated	$50	—	+91.8%	$26.07
2024-11-06	Needham	Mike Matson	$70	$65	-5	+50.1%	$43.31
2024-07-02	Evercore ISI	Vijay Kumar	Initiated	$62	—	+39.8%	$44.35
2024-05-03	Robert W. Baird	Jeff Johnson	Initiated	$64	—	+22.8%	$52.13
2023-12-15	Needham	Mike Matson	Initiated	$70	—	+30.6%	$53.58
2023-05-12	Wells Fargo	Vik Chopra	Initiated	$67	—	+20.1%	$55.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ENOV receives an overall rating of C-. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-05-11	C	C-
2026-05-11	C-	C
2026-04-01	C	C-
2026-03-05	C+	C
2026-03-02	C	C+
2026-02-27	C+	C
2026-02-26	B-	C+
2026-01-30	C+	B-
2026-01-30	B-	C+
2026-01-28	C+	B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 19 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ENOV scores highest in Value (41/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

-0.29

Distress Zone

Piotroski F-Score

4/9

✗ ✓ ✗ ✓ ✗ ✗ ✗ ✓ ✓

Beneish M-Score

-4.41

Unlikely Manipulator

Ohlson O-Score

-5.99

Bankruptcy prob: 0.3%

Low Risk

Credit Rating

Score: 26.0/100

Trend: Deteriorating

Earnings Quality

—

OCF/NI: -0.25x

Accruals: -31.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ENOV scores -0.29, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ENOV scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ENOV's score of -4.41 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ENOV's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ENOV receives an estimated rating of B (score: 26.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-0.92x

PEG

0.02x

P/S

0.45x

P/B

0.69x

P/FCF

20.36x

P/OCF

4.80x

EV/EBITDA

-3.67x

EV/Revenue

1.15x

EV/EBIT

-2.62x

EV/FCF

41.67x

Earnings Yield

-85.01%

FCF Yield

4.91%

Shareholder Yield

0.04%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ENOV currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.031

NI / EBT

Interest Burden

1.055

EBT / EBIT

EBIT Margin

-0.441

EBIT / Rev

Asset Turnover

0.523

Rev / Assets

Equity Multiplier

2.167

Assets / Equity

ROE

-54.3%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ENOV's ROE of -54.3% is driven by Asset Turnover (0.523), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.03 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$17.76

Median 1Y

$13.75

5th Pctile

$6.24

95th Pctile

$30.33

Ann. Volatility

47.9%

Analyst Target

$35.71

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Damien McDonald	$634,615	$7,262,644	$9,242,161

CEO Pay Ratio

91:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $12,452,638

Avg Employee Cost (SGA/emp): $137,164

Employees: 7,802

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

7,802

+5.9% YoY

Revenue / Employee

$288,138

Rev: $2,248,049,000

Profit / Employee

$-151,812

NI: $-1,184,440,000

SGA / Employee

$137,164

Avg labor cost proxy

R&D / Employee

$15,423

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	2.7%	1.8%	1.5%	3.0%	0.6%	-0.3%	-1.3%	-4.0%	-2.2%	-1.0%	-2.4%	-2.7%	-3.5%	-27.6%	-27.3%	-28.2%	-51.1%	-58.5%	-55.5%	-54.3%	-54.33%
ROA	1.4%	0.9%	0.8%	1.9%	0.4%	-0.2%	-0.8%	-3.1%	-1.7%	-0.8%	-1.7%	-1.8%	-2.4%	-17.9%	-15.6%	-15.8%	-27.4%	-27.7%	-26.1%	-25.1%	-25.07%
ROIC	8.7%	-2.6%	-0.0%	0.3%	0.2%	-1.5%	7.0%	-1.7%	-1.8%	-1.3%	-1.3%	-1.8%	-2.0%	-15.6%	-15.4%	-15.0%	-29.9%	-16.3%	-14.4%	-13.5%	-13.52%
ROCE	0.9%	0.8%	-0.4%	3.5%	2.1%	0.6%	0.7%	-2.6%	-1.4%	-1.1%	-1.7%	-1.6%	-1.8%	-18.3%	-17.2%	-17.1%	-33.1%	-34.4%	-32.4%	-32.1%	-32.11%
Gross Margin	55.0%	40.9%	54.8%	54.6%	56.2%	56.7%	57.9%	58.0%	58.2%	58.1%	57.7%	55.0%	56.7%	54.8%	59.5%	59.3%	59.9%	60.7%	54.9%	61.6%	61.64%
Operating Margin	-4.5%	5.4%	-8.2%	1.4%	-4.7%	-6.9%	-6.1%	-3.4%	-4.9%	-1.3%	-6.8%	-8.4%	-6.3%	-1.2%	-8.4%	-3.0%	-1.0%	8.4%	3.4%	3.0%	2.99%
Net Margin	7.2%	-0.2%	4.0%	19.5%	-17.4%	-9.4%	-5.7%	-2.3%	-0.7%	0.7%	-13.9%	-3.5%	-6.2%	-1.3%	-10.0%	-6.5%	-1.0%	-90.4%	-1.5%	-0.2%	-0.20%
EBITDA Margin	14.7%	11.8%	9.4%	43.6%	-5.7%	13.7%	6.8%	8.8%	8.6%	15.1%	2.7%	10.5%	7.9%	-1.1%	4.2%	9.8%	-87.0%	-73.8%	15.8%	14.9%	14.86%
FCF Margin	11.6%	9.6%	7.3%	2.2%	-1.1%	-10.3%	-9.1%	-6.5%	-6.0%	0.7%	-2.1%	-3.1%	-3.1%	-3.2%	-1.8%	-0.2%	1.0%	0.9%	1.6%	2.8%	2.77%
OCF Margin	16.0%	13.6%	12.2%	7.2%	3.5%	-3.6%	-2.1%	1.2%	1.8%	7.9%	5.0%	3.7%	4.7%	5.4%	6.9%	8.6%	9.7%	9.7%	10.7%	11.8%	11.76%
ROE 3Y Avg	snapshot only																				-36.48%
ROE 5Y Avg	snapshot only																				-22.03%
ROA 3Y Avg	snapshot only																				-15.80%
ROIC 3Y Avg	snapshot only																				-10.39%
ROIC Economic	snapshot only																				-13.52%
Cash ROA	snapshot only																				7.17%
Cash ROIC	snapshot only																				9.53%
CROIC	snapshot only																				2.25%
NOPAT Margin	snapshot only																				-16.68%
Pretax Margin	snapshot only																				-46.52%
R&D / Revenue	snapshot only																				5.41%
SGA / Revenue	snapshot only																				46.57%
SBC / Revenue	snapshot only																				1.54%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	40.25	70.19	56.19	26.35	106.57	-218.35	-56.20	-25.23	-38.44	-91.96	-41.69	-27.38	-20.38	-3.10	-2.28	-2.31	-1.33	-1.28	-1.13	-1.18	-0.916
P/S Ratio	1.77	1.92	1.80	1.42	1.15	1.86	1.82	2.15	1.73	1.79	1.88	1.30	1.21	1.22	0.86	0.87	0.81	0.67	0.56	0.56	0.445
P/B Ratio	0.94	1.09	0.83	0.88	0.73	0.84	0.84	1.01	0.84	0.89	1.03	0.75	0.73	1.00	0.71	0.74	0.90	1.02	0.87	0.88	0.693
P/FCF	15.25	19.97	24.76	65.46	-108.45	-17.99	-19.93	-33.01	-28.64	239.60	-91.48	-41.14	-39.25	-38.11	-47.39	-483.57	79.88	75.96	35.79	20.36	20.359
P/OCF	11.06	14.12	14.77	19.82	32.68	—	—	183.84	93.95	22.66	37.38	34.90	25.95	22.56	12.48	10.16	8.38	6.96	5.29	4.80	4.798
EV/EBITDA	18.12	20.15	22.98	8.45	9.02	13.29	13.85	39.52	21.07	20.97	30.49	22.22	21.42	-8.14	-6.92	-7.06	-3.26	-3.46	-3.53	-3.67	-3.668
EV/Revenue	2.44	2.49	2.55	1.50	1.27	2.06	2.03	2.42	1.99	2.08	2.62	2.02	1.90	1.86	1.52	1.52	1.44	1.27	1.17	1.15	1.155
EV/EBIT	93.18	107.88	-170.85	24.85	37.44	146.15	114.52	-36.44	-59.39	-75.11	-57.84	-49.86	-42.66	-5.12	-4.33	-4.38	-2.53	-2.57	-2.55	-2.62	-2.619
EV/FCF	20.97	25.86	35.11	69.07	-120.19	-19.92	-22.23	-37.14	-32.95	278.79	-127.55	-64.08	-61.54	-58.28	-83.83	-843.05	141.71	143.40	74.14	41.67	41.667
Earnings Yield	2.5%	1.4%	1.8%	3.8%	0.9%	-0.5%	-1.8%	-4.0%	-2.6%	-1.1%	-2.4%	-3.7%	-4.9%	-32.2%	-43.8%	-43.3%	-75.2%	-78.3%	-88.4%	-85.0%	-85.01%
FCF Yield	6.6%	5.0%	4.0%	1.5%	-0.9%	-5.6%	-5.0%	-3.0%	-3.5%	0.4%	-1.1%	-2.4%	-2.5%	-2.6%	-2.1%	-0.2%	1.3%	1.3%	2.8%	4.9%	4.91%
PEG Ratio	snapshot only																				0.015
EV/OCF	snapshot only																				9.820
EV/Gross Profit	snapshot only																				1.949
Shareholder Yield	snapshot only																				0.04%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	1.77	2.25	1.62	1.33	1.18	1.41	2.38	2.51	2.40	2.43	2.10	2.26	2.27	2.17	2.55	2.25	2.22	2.02	2.04	1.98	1.985
Quick Ratio	0.97	1.90	1.03	0.83	0.69	0.65	1.13	1.23	1.08	1.16	1.03	1.08	1.12	1.13	1.32	1.15	1.16	1.04	1.05	1.00	1.002
Debt/Equity	0.39	0.47	0.49	0.15	0.15	0.10	0.10	0.14	0.14	0.16	0.43	0.43	0.42	0.55	0.56	0.57	0.71	0.93	0.96	0.93	0.927
Net Debt/Equity	0.35	0.32	0.35	0.05	0.08	0.09	0.10	0.13	0.13	0.15	0.41	0.42	0.41	0.53	0.54	0.55	0.70	0.90	0.93	0.92	0.918
Debt/Assets	0.22	0.25	0.27	0.12	0.12	0.08	0.08	0.11	0.11	0.12	0.26	0.26	0.25	0.30	0.30	0.29	0.33	0.36	0.37	0.36	0.364
Debt/EBITDA	5.49	6.70	9.59	1.38	1.71	1.39	1.53	4.72	2.96	3.16	9.05	8.16	7.96	-2.92	-3.09	-3.10	-1.46	-1.67	-1.87	-1.89	-1.893
Net Debt/EBITDA	4.94	4.59	6.77	0.44	0.88	1.28	1.43	4.39	2.76	2.95	8.62	7.95	7.76	-2.82	-3.01	-3.01	-1.42	-1.63	-1.83	-1.88	-1.876
Interest Coverage	0.77	0.83	-0.51	2.66	1.78	0.69	1.25	-4.87	-2.58	-2.40	-2.41	-1.65	-1.71	-13.41	-16.30	-19.70	-26.36	-23.76	-18.39	-18.23	-18.232
Equity Multiplier	1.74	1.84	1.84	1.29	1.30	1.24	1.25	1.29	1.28	1.32	1.66	1.66	1.67	1.84	1.86	1.95	2.19	2.57	2.59	2.55	2.550
Cash Ratio	snapshot only																				0.021
Debt Service Coverage	snapshot only																				-13.017
Cash to Debt	snapshot only																				0.009
FCF to Debt	snapshot only																				0.046
Defensive Interval	snapshot only																				89.8 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.32	0.33	0.26	0.36	0.35	0.24	0.25	0.36	0.38	0.39	0.37	0.39	0.40	0.46	0.42	0.42	0.45	0.53	0.52	0.52	0.523
Inventory Turnover	1.97	3.11	1.50	2.10	1.87	1.77	1.08	1.63	1.58	1.60	1.49	1.53	1.60	1.82	1.60	1.49	1.52	1.60	1.58	1.52	1.521
Receivables Turnover	4.40	6.78	3.49	5.04	5.05	5.99	3.40	5.87	6.20	6.11	5.49	5.52	5.91	6.03	5.27	5.16	5.37	5.29	5.18	5.13	5.129
Payables Turnover	3.34	5.89	2.31	3.64	3.44	4.77	2.02	4.55	4.61	5.34	4.97	5.34	6.10	5.95	5.44	4.99	5.21	4.92	4.69	4.60	4.603
DSO	83	54	104	72	72	61	107	62	59	60	66	66	62	60	69	71	68	69	70	71	71.2 days
DIO	185	118	244	174	195	206	339	224	231	228	245	238	228	200	229	244	240	229	230	240	239.9 days
DPO	109	62	158	100	106	77	181	80	79	68	73	68	60	61	67	73	70	74	78	79	79.3 days
Cash Conversion Cycle	159	109	191	146	161	190	266	206	210	220	238	236	230	199	231	242	238	224	223	232	231.8 days
Fixed Asset Turnover	snapshot only																				3.813
Operating Cycle	snapshot only																				311.1 days
Cash Velocity	snapshot only																				182.807
Capital Intensity	snapshot only																				1.640

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	-22.6%	-14.7%	-32.5%	-24.9%	-10.1%	-40.3%	-24.6%	-24.4%	-23.7%	9.2%	14.0%	17.6%	20.5%	23.5%	18.3%	14.4%	11.6%	6.7%	6.0%	4.9%	4.89%
Net Income	15.3%	68.1%	18.2%	22.8%	-78.1%	-1.2%	-1.8%	-2.2%	-4.2%	-1.5%	-58.4%	34.6%	-59.3%	-23.8%	-8.9%	-8.1%	-10.5%	-43.5%	-40.5%	-33.1%	-33.12%
EPS	13.4%	22.0%	2.7%	15.5%	-78.5%	-1.2%	-1.8%	-2.2%	-4.2%	-1.5%	-57.4%	35.1%	-56.1%	-22.2%	-8.5%	-7.8%	-10.2%	-47.5%	-40.5%	-31.3%	-31.25%
FCF	1.1%	34.6%	-30.8%	-82.2%	-1.1%	-1.6%	-1.9%	-3.3%	-3.4%	1.1%	74.4%	43.1%	38.4%	-6.3%	-4.4%	93.4%	1.4%	1.3%	1.9%	17.1%	17.11%
EBITDA	-22.8%	-20.9%	-45.1%	-3.8%	-6.0%	-25.2%	-0.3%	-73.9%	-48.8%	-29.8%	-33.2%	74.6%	13.2%	-3.8%	-4.0%	-3.7%	-6.6%	-71.4%	-59.9%	-53.2%	-53.16%
Op. Income	-52.3%	-44.4%	-1.0%	-91.7%	-86.7%	-1.8%	-38.0%	-7.0%	-8.1%	7.7%	-15.6%	-23.3%	-32.4%	-10.8%	-9.4%	-6.2%	-10.1%	24.4%	34.1%	36.2%	36.20%
OCF Growth	snapshot only																				43.63%
Asset Growth	snapshot only																				-25.00%
Equity Growth	snapshot only																				-42.71%
Debt Growth	snapshot only																				-6.54%
Shares Change	snapshot only																				1.42%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	-12.0%	-10.6%	-17.7%	-17.1%	-16.6%	-24.6%	-22.8%	-19.9%	-19.0%	-17.8%	-16.6%	-12.6%	-6.2%	-7.0%	0.6%	0.6%	0.8%	12.9%	12.6%	12.2%	12.17%
Revenue 5Y	-8.5%	-6.4%	-10.2%	-9.9%	-9.5%	-15.0%	-14.9%	-14.3%	-14.1%	-14.2%	-13.7%	-12.7%	-11.8%	-10.4%	-9.1%	-7.1%	-6.5%	-6.0%	-6.2%	-4.4%	-4.36%
EPS 3Y	-9.6%	-31.9%	-4.5%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	-9.3%	-18.4%	-18.7%	-11.0%	-36.7%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	-0.3%	-20.0%	2.1%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	-4.5%	-11.0%	-14.0%	-6.0%	-33.2%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	47.0%	-0.7%	-7.2%	3.0%	-10.5%	-20.6%	-24.4%	-39.6%	-28.1%	-25.4%	-28.5%	-24.0%	-18.3%	—	—	—	—	—	—	—	—
EBITDA 5Y	-4.6%	-4.5%	-9.9%	-0.6%	-5.9%	7.5%	7.9%	-7.2%	8.9%	-12.5%	-11.9%	-13.0%	-16.1%	—	—	—	—	—	—	—	—
Gross Profit 3Y	0.8%	1.6%	-5.7%	-7.4%	-9.1%	-16.6%	-15.5%	-11.7%	-10.3%	-8.4%	-7.0%	-4.9%	0.4%	-0.2%	5.9%	6.7%	7.3%	15.7%	14.2%	13.5%	13.50%
Gross Profit 5Y	-1.1%	0.7%	-2.2%	-1.9%	-1.4%	-4.8%	-4.0%	-3.1%	-2.7%	-2.6%	-2.9%	-3.5%	-4.2%	-4.7%	-4.0%	-1.4%	-0.4%	0.9%	0.4%	1.4%	1.39%
Op. Income 3Y	97.6%	-27.5%	—	-56.7%	-59.2%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	-17.0%	-17.6%	—	-44.7%	-47.1%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	34.2%	17.1%	27.6%	-20.9%	—	—	—	—	—	-59.1%	—	—	—	—	—	—	—	—	—	—	—
FCF 5Y	10.0%	6.5%	-6.3%	-28.0%	—	—	—	—	—	-39.4%	—	—	—	—	—	—	-29.6%	-36.1%	-30.5%	-24.7%	-24.67%
OCF 3Y	23.8%	16.3%	18.0%	-8.8%	-26.4%	—	—	-55.4%	-49.5%	-23.5%	-34.8%	-42.4%	-37.8%	-31.7%	-16.8%	6.9%	41.7%	—	—	1.4%	1.42%
OCF 5Y	8.9%	7.6%	-1.1%	-11.8%	-21.7%	—	—	-34.2%	-31.6%	-9.8%	-10.2%	-19.0%	-13.3%	-2.8%	-10.6%	-2.5%	-1.9%	-6.4%	-6.0%	-6.2%	-6.17%
Assets 3Y	7.3%	8.8%	-6.9%	-23.1%	-22.6%	-16.7%	-16.8%	-14.6%	-15.0%	-15.0%	-12.1%	-10.4%	-11.4%	-17.9%	-16.9%	3.7%	-0.1%	-3.5%	-3.8%	-5.4%	-5.36%
Assets 5Y	4.0%	5.9%	5.7%	-7.7%	-8.3%	-8.7%	-9.0%	-7.2%	-7.3%	-7.3%	-12.2%	-11.3%	-10.4%	-8.6%	-8.1%	-6.8%	-9.1%	-12.2%	-13.8%	-13.0%	-13.01%
Equity 3Y	12.0%	12.2%	8.7%	4.1%	4.5%	0.1%	1.5%	1.0%	0.3%	-1.2%	-8.0%	-8.6%	-10.1%	-17.8%	-17.1%	-9.6%	-16.0%	-24.4%	-24.6%	-24.6%	-24.62%
Book Value 3Y	1.5%	-4.4%	1.7%	-1.9%	-1.2%	-4.7%	-3.2%	-4.9%	-5.3%	-6.6%	-12.4%	-10.6%	-11.6%	-15.5%	-18.3%	-10.8%	-17.3%	-25.6%	-25.7%	-26.0%	-25.99%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.67	0.67	0.63	0.76	0.78	0.74	0.82	0.91	0.96	0.91	0.89	0.89	0.82	0.67	0.55	0.50	0.46	0.20	0.21	0.13	0.127
Earnings Stability	0.08	0.07	0.07	0.00	0.00	0.01	0.01	0.01	0.03	0.02	0.02	0.13	0.15	0.07	0.11	0.56	0.53	0.76	0.80	0.83	0.834
Margin Stability	0.82	0.83	0.82	0.83	0.83	0.80	0.79	0.79	0.78	0.76	0.77	0.80	0.83	0.85	0.88	0.87	0.87	0.87	0.87	0.89	0.889
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earnings Persistence	0.20	0.50	0.50	0.50	0.50	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.83	0.84	0.87	0.868
Earnings Smoothness	—	0.49	0.83	0.80	0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	0.10	0.09	0.08	0.02	-0.00	-0.02	-0.03	-0.07	-0.04	-0.02	-0.02	-0.02	-0.03	-0.32	-0.29	-0.29	-0.65	-0.63	-0.60	-0.57	-0.572
Gross Margin Trend	0.06	0.04	0.06	0.05	0.04	0.12	0.11	0.11	0.10	0.08	0.06	0.04	0.04	-0.01	-0.01	0.00	0.01	0.03	0.01	0.02	0.019
FCF Margin Trend	0.09	0.06	0.02	-0.04	-0.09	-0.18	-0.16	-0.12	-0.11	0.01	-0.01	-0.01	0.00	0.02	0.04	0.05	0.06	0.02	0.04	0.04	0.044
Sustainable Growth Rate	2.7%	1.8%	1.5%	3.0%	0.6%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Internal Growth Rate	1.4%	0.9%	0.8%	2.0%	0.4%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	3.64	4.97	3.80	1.33	3.26	4.20	0.66	-0.14	-0.41	-4.06	-1.12	-0.78	-0.79	-0.14	-0.18	-0.23	-0.16	-0.18	-0.21	-0.25	-0.245
FCF/OCF	0.73	0.71	0.60	0.30	-0.30	2.89	4.29	-5.57	-3.28	0.09	-0.41	-0.85	-0.66	-0.59	-0.26	-0.02	0.10	0.09	0.15	0.24	0.236
FCF/Net Income	snapshot only																				-0.058
CapEx/Revenue	4.4%	4.0%	4.9%	5.0%	4.6%	6.7%	7.0%	7.7%	7.9%	7.2%	7.1%	6.9%	7.8%	8.6%	8.7%	8.8%	8.7%	8.8%	9.1%	9.0%	8.99%
CapEx/Depreciation	snapshot only																				0.713
Accruals Ratio	-0.04	-0.04	-0.02	-0.01	-0.01	0.01	-0.00	-0.04	-0.02	-0.04	-0.04	-0.03	-0.04	-0.20	-0.18	-0.19	-0.32	-0.33	-0.32	-0.31	-0.312
Sloan Accruals	snapshot only																				-0.091
Cash Flow Adequacy	snapshot only																				1.308

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—	0.0%	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.04%
Net Buyback Yield	-17.2%	-14.8%	-0.8%	-0.6%	-0.4%	-0.2%	-0.2%	-0.2%	-0.2%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.05%
Total Shareholder Return	-17.2%	-14.8%	-0.8%	-0.6%	-0.4%	-0.2%	-0.2%	-0.2%	-0.2%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.05%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	45.69	7.68	-1.06	1.18	0.58	6.42	-9.13	1.07	0.97	0.50	0.70	0.73	0.84	1.00	1.01	1.04	1.03	1.02	1.03	1.03	1.031
Interest Burden (EBT/EBIT)	0.04	0.15	2.03	0.76	0.55	-0.09	0.20	1.21	1.39	1.42	1.41	1.61	1.59	1.07	1.06	1.05	1.04	1.04	1.05	1.05	1.055
EBIT Margin	0.03	0.02	-0.01	0.06	0.03	0.01	0.02	-0.07	-0.03	-0.03	-0.05	-0.04	-0.04	-0.36	-0.35	-0.35	-0.57	-0.49	-0.46	-0.44	-0.441
Asset Turnover	0.32	0.33	0.26	0.36	0.35	0.24	0.25	0.36	0.38	0.39	0.37	0.39	0.40	0.46	0.42	0.42	0.45	0.53	0.52	0.52	0.523
Equity Multiplier	1.89	1.94	1.87	1.55	1.55	1.59	1.59	1.29	1.29	1.28	1.45	1.47	1.47	1.54	1.75	1.78	1.87	2.11	2.13	2.17	2.167

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$2.01	$1.13	$1.24	$2.13	$0.43	$-0.25	$-0.95	$-2.54	$-1.37	$-0.61	$-1.50	$-1.65	$-2.14	$-14.14	$-14.25	$-14.57	$-24.07	$-20.86	$-20.02	$-19.13	$-19.13
Book Value/Share	$86.49	$72.64	$84.55	$64.00	$62.93	$63.58	$63.38	$63.27	$63.06	$62.61	$60.50	$59.91	$59.83	$43.90	$46.09	$45.40	$35.58	$26.23	$26.01	$25.64	$25.68
Tangible Book/Share	$-12.03	$24.05	$-8.78	$8.25	$6.10	$6.52	$6.89	$5.57	$5.71	$4.22	$-9.41	$-8.16	$-8.26	$-7.67	$-8.10	$-9.60	$-8.43	$-8.19	$-7.53	$-6.65	$-6.65
Revenue/Share	$45.70	$41.19	$38.87	$39.50	$40.23	$28.82	$29.34	$29.85	$30.45	$31.27	$33.23	$34.89	$35.96	$36.11	$37.86	$38.55	$39.32	$39.58	$40.12	$39.87	$39.87
FCF/Share	$5.32	$3.96	$2.82	$0.86	$-0.42	$-2.97	$-2.68	$-1.94	$-1.84	$0.23	$-0.68	$-1.10	$-1.11	$-1.15	$-0.69	$-0.07	$0.40	$0.35	$0.63	$1.11	$1.11
OCF/Share	$7.33	$5.60	$4.73	$2.83	$1.41	$-1.03	$-0.63	$0.35	$0.56	$2.47	$1.67	$1.30	$1.68	$1.94	$2.61	$3.31	$3.82	$3.83	$4.28	$4.69	$4.69
Cash/Share	$3.35	$10.70	$12.16	$6.58	$4.71	$0.45	$0.40	$0.60	$0.59	$0.66	$1.21	$0.64	$0.64	$0.83	$0.68	$0.78	$0.59	$0.64	$0.58	$0.22	$0.22
EBITDA/Share	$6.15	$5.09	$4.31	$6.99	$5.66	$4.46	$4.31	$1.83	$2.88	$3.11	$2.86	$3.17	$3.19	$-8.24	$-8.31	$-8.31	$-17.43	$-14.52	$-13.29	$-12.55	$-12.55
Debt/Share	$33.74	$34.06	$41.37	$9.66	$9.70	$6.17	$6.58	$8.62	$8.53	$9.82	$25.84	$25.84	$25.41	$24.06	$25.69	$25.79	$25.38	$24.29	$24.84	$23.77	$23.77
Net Debt/Share	$30.39	$23.35	$29.21	$3.09	$4.98	$5.73	$6.18	$8.02	$7.94	$9.16	$24.63	$25.20	$24.77	$23.23	$25.01	$25.02	$24.79	$23.65	$24.25	$23.55	$23.55

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.295
Altman Z-Prime	snapshot only																				-1.441
Piotroski F-Score	7	6	7	5	6	3	6	6	5	5	3	4	3	3	5	4	4	5	4	4	4
Beneish M-Score	-1.73	-2.93	-1.65	-3.19	-3.30	-2.00	-3.27	-2.51	-2.54	-2.56	-2.26	-2.28	-2.23	-3.07	-3.36	-3.39	-4.25	-4.32	-4.26	-4.41	-4.407
Ohlson O-Score	snapshot only																				-5.987
Net-Net WC	snapshot only																				$-18.62
EVA	snapshot only																				$-666454640.00

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				B
Credit Score	33.19	36.04	24.51	58.82	45.98	46.62	53.26	45.84	43.33	45.38	29.34	29.75	30.53	32.55	35.30	34.36	30.24	30.24	30.34	26.04	26.043
Credit Grade	snapshot only																				15
Credit Trend	snapshot only																				-8.320
Implied Spread (bps)	snapshot only																				750.000
Industry Credit Rank	snapshot only																				12
Sector Credit Rank	snapshot only																				11

ENOV NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet